Search clinical trials for: Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (anti-PD-L1) antibody
Total 69 results
-
Hoffmann-La RocheCompletedTumorsFrance, United States, Denmark, Ireland, Italy, Turkey, United Kingdom, Canada, Brazil, Spain, Poland, Netherlands, Germany, Russian Federation, Austria, Finland, Norway, Switzerland
-
Genentech, Inc.CompletedNeoplasmsUnited States, Spain, Belgium, Korea, Republic of, Canada, Australia, France
-
Huabo Biopharm Co., Ltd.Recruiting
-
Hoffmann-La RocheCompletedSquamous Non-Small Cell Lung CancerUnited States, Spain, France, Australia, Germany, Taiwan, Canada, Argentina, Belgium, Singapore, Brazil, Netherlands, Israel, Portugal, Russian Federation, Japan, Italy, Chile, Latvia, Peru, Ukraine, Lithuania, Slovakia, Bulgaria, Mexico, Austri...
-
Hoffmann-La RocheCompletedCarcinoma, Non-Small-Cell LungChina, Korea, Republic of, Singapore, Thailand, Malaysia
-
Genentech, Inc.CompletedNon-Small Cell Lung CancerUnited States
-
Shanghai Zhongshan HospitalNot yet recruiting
-
PfizerWithdrawnBladder CancerPoland, United States
-
Hoffmann-La RocheCompletedColorectal CancerCanada, United States, Italy, Korea, Republic of, United Kingdom, Belgium, Russian Federation, Hong Kong, Spain, Australia, Poland
-
Genentech, Inc.Completed
-
Genentech, Inc.CompletedNon-Small Cell Lung CancerUnited States, France, United Kingdom, Belgium, Netherlands
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerCanada, Belgium, Brazil, China, Denmark, Portugal, Spain, United Kingdom, Argentina, Bulgaria, Colombia, Germany, India, Ireland, Italy, Luxembourg, Mexico, Poland, Romania, Slovakia, Switzerland, Vietnam, Kazakhstan, Czechia
-
Hoffmann-La RocheCompletedSmall Cell Lung CarcinomaKorea, Republic of, United States, Hungary, Poland, China, France, Greece, Spain, United Kingdom, Brazil, Italy, Germany, Mexico, Australia, Serbia, Russian Federation, Japan, Austria, Chile, Czechia, Taiwan
-
Hoffmann-La RocheCompletedRenal Cell CarcinomaKorea, Republic of, United States, France, Italy, United Kingdom, Canada, Australia, Brazil, Denmark, Spain, Turkey, Japan, Czechia, Singapore, Thailand, Taiwan, Russian Federation, Germany, Bosnia and Herzegovina, Poland, Mexico
-
Hoffmann-La RocheCompletedRenal Cell CarcinomaUnited States, Spain, Czechia, United Kingdom, Romania, France, Italy, Germany, Poland
-
Hoffmann-La RocheTerminatedAdvanced/Metastatic Head and Neck, Oesophageal and Cervical CancersKorea, Republic of, France, Spain, Belgium, United Kingdom, Singapore, Israel, Russian Federation, Taiwan, Switzerland, Turkey, United States, New Zealand, Poland, Germany
-
Hoffmann-La RocheCompletedCarcinoma, Non-Small-Cell LungUnited States, Spain, France, Belgium, Australia, Germany, Argentina, Japan, Brazil, Italy, Singapore, Russian Federation, Taiwan, Netherlands, Peru, Chile, Latvia, Ukraine, Mexico, Lithuania, Slovakia, Bulgaria, Portugal, Austria, Swit... and more
-
Megan Daly, MDNational Cancer Institute (NCI); Genentech, Inc.TerminatedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
Hoffmann-La RocheActive, not recruitingBreast NeoplasmsUnited States, Israel, Korea, Republic of
-
Hoffmann-La RocheCompletedCarcinoma, Non-Squamous Non-Small Cell LungUnited States, Israel, Belgium, Canada, Spain, Germany, Italy, France
-
Genentech, Inc.BioNTech SEActive, not recruitingMelanoma | Head and Neck Cancer | Colorectal Cancer | Non-Small Cell Lung Cancer | Bladder Cancer | Triple Negative Breast Cancer | Renal Cancer | Other Solid CancersUnited States, Belgium, Sweden, Germany, Canada, Spain, United Kingdom, Netherlands
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerFrance, Canada, Israel, Italy, Argentina, Brazil, China, Croatia, Germany, Greece, Slovakia, Turkey, Saudi Arabia, Japan, India, Spain, United States, Czechia, Romania, United Kingdom, Morocco, South Africa, Vietnam, Russian Federation
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedSolid TumorUnited States
-
The First Affiliated Hospital of Zhengzhou UniversityRecruitingEsophageal NeoplasmsChina
-
TheracosCompletedType 2 Diabetes MellitusUnited States, France, Spain, Japan
-
Hoffmann-La RocheCompletedTriple Negative Breast CancerUnited States, Korea, Republic of, Belgium, Canada, Germany, United Kingdom, Argentina, Australia, Brazil, Finland, France, Greece, Hungary, Poland, Slovenia, Spain, Taiwan, Turkey, Japan, Singapore, Colombia, Bosnia and Herzegovina, Guatema... and more
-
Hoffmann-La RocheActive, not recruitingNon-Small-Cell LungUnited States, Korea, Republic of, United Kingdom, Australia, France, Italy, Spain, Japan, Brazil, China, Germany, Poland, Thailand, Israel, Switzerland, Taiwan, Austria, Russian Federation, Ukraine, Hungary, Serbia, Slovenia, South... and more
-
Hoffmann-La RocheCompletedBladder CancerUnited States, France, Belgium, Korea, Republic of, United Kingdom, Czechia, Austria, Canada, Denmark, Greece, Italy, Netherlands, Portugal, Slovenia, Spain, Sweden, Turkey, Poland, Hungary, Switzerland, Japan, Taiwan, Australia, Norway, Germa... and more
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
MultiVir, Inc.UnknownLymphoma | Solid TumorUnited States
-
Second Affiliated Hospital, School of Medicine,...RecruitingCarcinoma, HepatocellularChina
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung CancerSpain, Italy, Poland, Brazil, Turkey, Serbia, France, Korea, Republic of, Romania, Hungary, Russian Federation, United States, United Kingdom, Germany, Greece, Japan, Thailand, Ukraine, China
-
LaNova Australia Pty LimitedRecruitingAdvanced Solid TumorAustralia
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHead and Neck CancerChina
-
Gustave Roussy, Cancer Campus, Grand ParisActive, not recruitingAtezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours (SABR-PDL1)Patients With Metastatic Tumours (Colorectal Cancer, Non-small Lung Cancer, Renal Cell Carcinoma or Sarcoma )France
-
German Breast GroupAstraZeneca; CelgeneCompleted
-
Shanghai Pulmonary Hospital, Shanghai, ChinaNot yet recruitingNon-small Cell Lung Cancer | Advanced Lung Carcinoma
-
LaNova Medicines LimitedTerminatedAdvanced Solid TumorUnited States
-
Shanghai Pulmonary Hospital, Shanghai, ChinaNot yet recruitingSafety Issues | Effect Increased
-
Sichuan UniversityRecruitingLung Cancer | Extensive-stage Small-cell Lung CancerChina
-
Bristol-Myers SquibbActive, not recruitingNeoplasms by SiteUnited States, Australia, Denmark, France, Switzerland, Austria, Canada, Germany, Japan, Netherlands, Norway, Spain, United Kingdom, Finland, Italy
-
Bristol-Myers SquibbCompletedHematologic NeoplasmsUnited States, Canada
-
Anwaar SaeedAstraZeneca; ExelixisActive, not recruitingHepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Esophageal AdenocarcinomaUnited States
-
Bristol-Myers SquibbCompletedNeoplasms by SiteUnited States
-
Peking Union Medical College HospitalRecruiting
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.SuspendedTriple Negative Breast CancerChina
-
Hunan Cancer HospitalCompletedAnti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal CancerMetastatic Colorectal AdenocarcinomaChina
-
CERESPIRCompletedAlzheimer's DiseaseUnited States
-
Henlix, IncUnknownHepatitis B, ChronicTaiwan